Updated risk-oriented strategy for acute lymphoblastic leukemia in adult patients 18–65 years: NILG ALL 10/07Renato Bassan, Alessandro Rambaldi, Filippo Marmont et al.|Blood Cancer Journal|2020Cited by 45
Final Results of Northern Italy Leukemia Group (NILG) Trial 10/07 Combining Pediatric-Type Therapy with Minimal Residual Disease Study and Risk-Oriented Hematopoietic Cell Transplantation in Adult Acute Lymphoblastic Leukemia (ALL)Renato Bassan, Alessandro Rambaldi, Arianna Masciulli et al.|Blood|2016Cited by 22
Current use and potential role of procalcitonin in the diagnostic work up and follow up of febrile neutropenia in hematological patientsBenedetto Bruno, Luisa Giaccone, Alessandro Busca et al.|Expert Review of Hematology|2017Cited by 21